1. National Institutes of Health, USA

Abstract

Retinoic acid receptor-related orphan receptors (ROR, nomenclature as agreed by the NC-IUPHAR Subcommittee on Nuclear Hormone Receptors [11, 3]) have yet to be assigned a definitive endogenous ligand, although RORα may be synthesized with a ‘captured’ agonist such as cholesterol [68, 67].

Contents

GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a reference work which is most usefully represented as an on-line database. As in any publication this work should be appropriately cited, and the papers it cites should also be recognized. This document provides a citation for the relevant parts of the database, and also provides a reference list for the research cited by those parts. For further details see [15].

Please note that the database version for the citations given in GtoPdb are to the most recent preceding version in which the family or its subfamilies and targets were substantially changed. The links below are to the current version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb curators.

Database links

References

1. Aicher TD, Taylor CB and Vanhuis CA. (2016) Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease Patent number: WO2016201225A1. Assignee: Lycera Corporation. Priority date: 11/06/2015. Publication date: 15/12/2016.
2. Akashi M and Takumi T. (2005) The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 12: 441-8 [PMID:15821743]
3. Alexander SPH, Cidlowski JA, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD and Pawson AJ et al.. (2019) THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors. Br J Pharmacol 176 Suppl 1: S229-S246 [PMID:31710718]
4. Amstadter AB, Sumner JA, Acierno R, Ruggiero KJ, Koenen KC, Kilpatrick DG, Galea S and Gelernter J. (2013) Support for association of RORA variant and post traumatic stress symptoms in a population-based study of hurricane exposed adults. Mol Psychiatry 18: 1148-9 [PMID:23319003]
5. André E, Conquet F, Steinmayr M, Stratton SC, Porciatti V and Becker-André M. (1998) Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 17: 3867-77 [PMID:9670004]
6. André E, Gawlas K and Becker-André M. (1998) A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina. Gene 216: 277-83 [PMID:9729429]
7. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Takahashi S and Hizawa N. (2013) Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J Immunol 190: 1056-65 [PMID:23293351]
8. Atkins GB, Hu X, Guenther MG, Rachez C, Freedman LP and Lazar MA. (1999) Coactivators for the orphan nuclear receptor RORalpha. Mol Endocrinol 13: 1550-7 [PMID:10478845]
9. Becker-André M, André E and DeLamarter JF. (1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194: 1371-9 [PMID:7916608]
10. Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat JH and Carlberg C. (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 269: 28531-4 [PMID:7961794]
11. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ and Laudet V. (2006) International Union of Pharmacology. LXVI. Orphan nuclear receptors. Pharmacol Rev 58: 798-836 [PMID:17132856]
12. Bitsch F, Aichholz R, Kallen J, Geisse S, Fournier B and Schlaeppi JM. (2003) Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach. Anal Biochem 323: 139-49 [PMID:14622968]
13. Bordji K, Grillasca JP, Gouze JN, Magdalou J, Schohn H, Keller JM, Bianchi A, Dauça M, Netter P and Terlain B. (2000) Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. J Biol Chem 275: 12243-50 [PMID:10766862]
14. Bronner SM, Zbieg JR and Crawford JJ. (2017) RORγ antagonists and inverse agonists: a patent review. Expert Opin Ther Pat 27: 101-112 [PMID:27629281]
15. Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
16. Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF and Becker-André M. (1994) RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8: 757-70 [PMID:7935491]
17. Chauvet C, Bois-Joyeux B, Fontaine C, Gervois P, Bernard MA, Staels B and Danan JL. (2005) The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha. Mol Endocrinol 19: 2517-26 [PMID:15941850]
18. Crumbley C, Wang Y, Kojetin DJ and Burris TP. (2010) Characterization of the core mammalian clock component, NPAS2, as a REV-ERBalpha/RORalpha target gene. J Biol Chem 285: 35386-92 [PMID:20817722]
19. Dai J, Choo MK, Park JM and Fisher DE. (2017) Topical ROR Inverse Agonists Suppress Inflammation in Mouse Models of Atopic Dermatitis and Acute Irritant Dermatitis. J Invest Dermatol 137: 2523-2531 [PMID:28774591]
20. Delerive P, Chin WW and Suen CS. (2002) Identification of Reverb(alpha) as a novel ROR(alpha) target gene. J Biol Chem 277: 35013-8 [PMID:12114512]
21. Devanna P and Vernes SC. (2014) A direct molecular link between the autism candidate gene RORa and the schizophrenia candidate MIR137. Sci Rep 4: 3994 [PMID:24500708]
22. Diefenbach A, Colonna M and Koyasu S. (2014) Development, differentiation, and diversity of innate lymphoid cells. Immunity 41: 354-65 [PMID:25238093]
23. Dong C. (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-48 [PMID:18408735]
24. Duan J, Dhar TGM, Marcoux D, Shi Q, Batt DG, Liu Q, Cherney RJ, Cornelius AMC, Srivastava AS and Bertrand MB et al.. (2016) Tricyclic sulfones as rorϒ modulators Patent number: WO2016179460A1. Assignee: Bristol-Myers Squibb. Priority date: 07/05/2015. Publication date: 10/11/2016.
25. Duez H and Staels B. (2010) Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler Thromb Vasc Biol 30: 1529-34 [PMID:20631353]
26. Dussault I and Giguère V. (1997) Differential regulation of the N-myc proto-oncogene by ROR alpha and RVR, two orphan members of the superfamily of nuclear hormone receptors. Mol Cell Biol 17: 1860-7 [PMID:9121434]
27. Eberl G and Littman DR. (2004) Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305: 248-51 [PMID:15247480]
28. Eberl G and Littman DR. (2003) The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol Rev 195: 81-90 [PMID:12969312]
29. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y and Littman DR. (2004) An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5: 64-73 [PMID:14691482]
30. Ersland KM, Christoforou A, Stansberg C, Espeseth T, Mattheisen M, Mattingsdal M, Hardarson GA, Hansen T, Fernandes CP and Giddaluru S et al.. (2012) Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders. PLoS ONE 7: e31687 [PMID:22384057]
31. Etain B, Jamain S, Milhiet V, Lajnef M, Boudebesse C, Dumaine A, Mathieu F, Gombert A, Ledudal K and Gard S et al.. (2014) Association between circadian genes, bipolar disorders and chronotypes. Chronobiol Int 31: 807-14 [PMID:24716566]
32. Fauber BP, Gobbi A, Robarge K, Zhou A, Barnard A, Cao J, Deng Y, Eidenschenk C, Everett C and Ganguli A et al.. (2015) Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists. Bioorg Med Chem Lett 25: 2907-12 [PMID:26048793]
33. Fauber BP and Magnuson S. (2014) Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc). J Med Chem 57: 5871-92 [PMID:24502334]
34. Fauber BP, René O, Deng Y, DeVoss J, Eidenschenk C, Everett C, Ganguli A, Gobbi A, Hawkins J and Johnson AR et al.. (2015) Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist. J Med Chem 58: 5308-22 [PMID:26061388]
35. Fitzsimmons RL, Lau P and Muscat GE. (2012) Retinoid-related orphan receptor alpha and the regulation of lipid homeostasis. J Steroid Biochem Mol Biol 130: 159-68 [PMID:21723946]
36. Flick AC, Jones P, Kaila N, Mente SR, Schnute ME, Trzupek JD, Vazquez ML, Xing L, Zhang L and Wennerstal GM et al.. (2016) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof Patent number: WO2016046755A1. Assignee: Pfizer Inc.. Priority date: 26/09/2014. Publication date: 31/03/2016.
37. Fu Y, Liu H, Ng L, Kim JW, Hao H, Swaroop A and Forrest D. (2014) Feedback induction of a photoreceptor-specific isoform of retinoid-related orphan nuclear receptor β by the rod transcription factor NRL. J Biol Chem 289: 32469-80 [PMID:25296752]
38. Gamboa-Meléndez MA, Huerta-Chagoya A, Moreno-Macías H, Vázquez-Cárdenas P, Ordóñez-Sánchez ML, Rodríguez-Guillén R, Riba L, Rodríguez-Torres M, Guerra-García MT and Guillén-Pineda LE et al.. (2012) Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population. Diabetes 61: 3314-21 [PMID:22923468]
39. Gege C. (2016) Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742. Expert Opin Ther Pat 26: 737-44 [PMID:26895086]
40. Genoux A, Dehondt H, Helleboid-Chapman A, Duhem C, Hum DW, Martin G, Pennacchio LA, Staels B, Fruchart-Najib J and Fruchart JC. (2005) Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha. Arterioscler Thromb Vasc Biol 25: 1186-92 [PMID:15790933]
41. Germain P, Staels B, Dacquet C, Spedding M and Laudet V. (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58: 685-704 [PMID:17132848]
42. Giguère V, Tini M, Flock G, Ong E, Evans RM and Otulakowski G. (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 8: 538-53 [PMID:7926749]
43. Greiner EF, Kirfel J, Greschik H, Huang D, Becker P, Kapfhammer JP and Schüle R. (2000) Differential ligand-dependent protein-protein interactions between nuclear receptors and a neuronal-specific cofactor. Proc Natl Acad Sci USA 97: 7160-5 [PMID:10860982]
44. Guillaumond F, Dardente H, Giguère V and Cermakian N. (2005) Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20: 391-403 [PMID:16267379]
45. Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM and Takei F. (2012) Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37: 463-74 [PMID:22981535]
46. Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W, Kusumi K, Russell LB, Mueller KL, van Berkel V, Birren BW, Kruglyak L and Lander ES. (1996) Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 379: 736-9 [PMID:8602221]
47. Harding HP, Atkins GB, Jaffe AB, Seo WJ and Lazar MA. (1997) Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development. Mol Endocrinol 11: 1737-46 [PMID:9328355]
48. He YW, Deftos ML, Ojala EW and Bevan MJ. (1998) RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9: 797-806 [PMID:9881970]
49. Hirose T, Smith RJ and Jetten AM. (1994) ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 205: 1976-83 [PMID:7811290]
50. Hoorweg K, Peters CP, Cornelissen F, Aparicio-Domingo P, Papazian N, Kazemier G, Mjösberg JM, Spits H and Cupedo T. (2012) Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells. Front Immunol 3: 72 [PMID:22566953]
51. Hu X, Liu X, Moisan J, Wang Y, Lesch CA, Spooner C, Morgan RW, Zawidzka EM, Mertz D and Bousley D et al.. (2016) Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity. Oncoimmunology 5: e1254854 [PMID:28123897]
52. Hu X, Wang Y, Hao LY, Liu X, Lesch CA, Sanchez BM, Wendling JM, Morgan RW, Aicher TD and Carter LL et al.. (2015) Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists. Nat Chem Biol 11: 141-7 [PMID:25558972]
53. Huang Z, Xie H, Wang R and Sun Z. (2007) Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity. Expert Opin Ther Targets 11: 737-43 [PMID:17504012]
54. Huh JR, Leung MW, Huang P, Ryan DA, Krout MR, Malapaka RR, Chow J, Manel N, Ciofani M and Kim SV et al.. (2011) Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature 472: 486-90 [PMID:21441909]
55. Huh JR and Littman DR. (2012) Small molecule inhibitors of RORγt: targeting Th17 cells and other applications. Eur J Immunol 42: 2232-7 [PMID:22949321]
56. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-33 [PMID:16990136]
57. Ivanov II, Zhou L and Littman DR. (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19: 409-17 [PMID:18053739]
58. Jabaudon D, Shnider SJ, Tischfield DJ, Galazo MJ and Macklis JD. (2012) RORβ induces barrel-like neuronal clusters in the developing neocortex. Cereb Cortex 22: 996-1006 [PMID:21799210]
59. Jaradat M, Stapleton C, Tilley SL, Dixon D, Erikson CJ, McCaskill JG, Kang HS, Angers M, Liao G and Collins J et al.. (2006) Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation. Am J Respir Crit Care Med 174: 1299-309 [PMID:16973978]
60. Jetten AM. (2004) Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr Drug Targets Inflamm Allergy 3: 395-412 [PMID:15584888]
61. Jetten AM. (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7: e003 [PMID:19381306]
62. Jetten AM. (2011) Immunology: A helping hand against autoimmunity. Nature 472: 421-2 [PMID:21525918]
63. Jetten AM, Kang HS and Takeda Y. (2013) Retinoic acid-related orphan receptors α and γ: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity. Front Endocrinol (Lausanne) 4: 1 [PMID:23355833]
64. Jin L, Martynowski D, Zheng S, Wada T, Xie W and Li Y. (2010) Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol Endocrinol 24: 923-9 [PMID:20203100]
65. Johnson DR, Lovett JM, Hirsch M, Xia F and Chen JD. (2004) NuRD complex component Mi-2beta binds to and represses RORgamma-mediated transcriptional activation. Biochem Biophys Res Commun 318: 714-8 [PMID:15144897]
66. Jolly S, Journiac N, Naudet F, Gautheron V, Mariani J and Vernet-der Garabedian B. (2011) Cell-autonomous and non-cell-autonomous neuroprotective functions of RORα in neurons and astrocytes during hypoxia. J Neurosci 31: 14314-23 [PMID:21976517]
67. Kallen J, Schlaeppi JM, Bitsch F, Delhon I and Fournier B. (2004) Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. J Biol Chem 279: 14033-8 [PMID:14722075]
68. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I and Fournier B. (2002) X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10: 1697-707 [PMID:12467577]
69. Kang HS, Angers M, Beak JY, Wu X, Gimble JM, Wada T, Xie W, Collins JB, Grissom SF and Jetten AM. (2007) Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism. Physiol Genomics 31: 281-94 [PMID:17666523]
70. Kang HS, Okamoto K, Takeda Y, Beak JY, Gerrish K, Bortner CD, DeGraff LM, Wada T, Xie W and Jetten AM. (2011) Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis. Physiol Genomics 43: 818-28 [PMID:21540300]
71. Kiss EA and Diefenbach A. (2012) Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes. Front Immunol 3: 124 [PMID:22666222]
72. Kojetin DJ and Burris TP. (2014) REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov 13: 197-216 [PMID:24577401]
73. Kono M, Ochida A, Oda T, Imada T, Banno Y, Taya N, Masada S, Kawamoto T, Yonemori K and Nara Y et al.. (2018) Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist. J Med Chem 61: 2973-2988 [PMID:29510038]
74. Kumar N, Lyda B, Chang MR, Lauer JL, Solt LA, Burris TP, Kamenecka TM and Griffin PR. (2012) Identification of SR2211: a potent synthetic RORγ-selective modulator. ACS Chem Biol 7: 672-7 [PMID:22292739]
75. Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, Busby SA, Garcia-Ordonez RD, Burris TP and Griffin PR. (2010) The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 77: 228-36 [PMID:19887649]
76. Kurebayashi S, Nakajima T, Kim SC, Chang CY, McDonnell DP, Renaud JP and Jetten AM. (2004) Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma. Biochem Biophys Res Commun 315: 919-27 [PMID:14985100]
77. Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F and Jetten AM. (2000) Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci USA 97: 10132-7 [PMID:10963675]
78. Lau P, Bailey P, Dowhan DH and Muscat GE. (1999) Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD. Nucleic Acids Res 27: 411-20 [PMID:9862959]
79. Lau P, Fitzsimmons RL, Pearen MA, Watt MJ and Muscat GE. (2011) Homozygous staggerer (sg/sg) mice display improved insulin sensitivity and enhanced glucose uptake in skeletal muscle. Diabetologia 54: 1169-80 [PMID:21279323]
80. Lau P, Fitzsimmons RL, Raichur S, Wang SC, Lechtken A and Muscat GE. (2008) The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity. J Biol Chem 283: 18411-21 [PMID:18441015]
81. Lee JM, Kim IS, Kim H, Lee JS, Kim K, Yim HY, Jeong J, Kim JH, Kim JY, Lee H, Seo SB, Kim H, Rosenfeld MG, Kim KI and Baek SH. (2010) RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol Cell 37: 183-95 [PMID:20122401]
82. Liu H, Kim SY, Fu Y, Wu X, Ng L, Swaroop A and Forrest D. (2013) An isoform of retinoid-related orphan receptor β directs differentiation of retinal amacrine and horizontal interneurons. Nat Commun 4: 1813 [PMID:23652001]
83. Logue MW, Baldwin C, Guffanti G, Melista E, Wolf EJ, Reardon AF, Uddin M, Wildman D, Galea S and Koenen KC et al.. (2013) A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry 18: 937-42 [PMID:22869035]
84. Marciano DP, Chang MR, Corzo CA, Goswami D, Lam VQ, Pascal BD and Griffin PR. (2014) The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs. Cell Metab 19: 193-208 [PMID:24440037]
85. Marcoux D, Duan JJ, Shi Q, Cherney RJ, Srivastava AS, Cornelius L, Batt DG, Liu Q, Beaudoin-Bertrand M and Weigelt CA et al.. (2019) Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy. J Med Chem 62: 9931-9946 [PMID:31638797]
86. Matsui T. (1996) Differential activation of the murine laminin B1 gene promoter by RAR alpha, ROR alpha, and AP-1. Biochem Biophys Res Commun 220: 405-10 [PMID:8645318]
87. Matsumura R, Matsubara C, Node K, Takumi T and Akashi M. (2013) Nuclear receptor-mediated cell-autonomous oscillatory expression of the circadian transcription factor, neuronal PAS domain protein 2 (NPAS2). J Biol Chem 288: 36548-53 [PMID:24196956]
88. Matysiak-Scholze U and Nehls M. (1997) The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4. Genomics 43: 78-84 [PMID:9226375]
89. McBroom LD, Flock G and Giguère V. (1995) The nonconserved hinge region and distinct amino-terminal domains of the ROR alpha orphan nuclear receptor isoforms are required for proper DNA bending and ROR alpha-DNA interactions. Mol Cell Biol 15: 796-808 [PMID:7823947]
90. McKenzie AN, Spits H and Eberl G. (2014) Innate lymphoid cells in inflammation and immunity. Immunity 41: 366-74 [PMID:25238094]
91. Medvedev A, Yan ZH, Hirose T, Giguère V and Jetten AM. (1996) Cloning of a cDNA encoding the murine orphan receptor RZR/ROR gamma and characterization of its response element. Gene 181: 199-206 [PMID:8973331]
92. Meissburger B, Ukropec J, Roeder E, Beaton N, Geiger M, Teupser D, Civan B, Langhans W, Nawroth PP and Gasperikova D et al.. (2011) Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol Med 3: 637-51 [PMID:21853531]
93. Melén E, Kho AT, Sharma S, Gaedigk R, Leeder JS, Mariani TJ, Carey VJ, Weiss ST and Tantisira KG. (2011) Expression analysis of asthma candidate genes during human and murine lung development. Respir Res 12: 86 [PMID:21699702]
94. Meyer T, Kneissel M, Mariani J and Fournier B. (2000) In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc Natl Acad Sci USA 97: 9197-202 [PMID:10900268]
95. Miller MW, Wolf EJ, Logue MW and Baldwin CT. (2013) The retinoid-related orphan receptor alpha (RORA) gene and fear-related psychopathology. J Affect Disord 151: 702-8 [PMID:24007783]
96. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M and Cookson WO et al.. (2010) A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363: 1211-21 [PMID:20860503]
97. Mongrain V, Ruan X, Dardente H, Fortier EE and Cermakian N. (2008) Clock-dependent and independent transcriptional control of the two isoforms from the mouse Rorgamma gene. Genes Cells 13: 1197-210 [PMID:19076641]
98. Moraitis AN, Giguère V and Thompson CC. (2002) Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol Cell Biol 22: 6831-41 [PMID:12215540]
99. Mukherji A, Kobiita A, Ye T and Chambon P. (2013) Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 153: 812-27 [PMID:23663780]
100. Nakajima Y, Ikeda M, Kimura T, Honma S, Ohmiya Y and Honma K. (2004) Bidirectional role of orphan nuclear receptor RORalpha in clock gene transcriptions demonstrated by a novel reporter assay system. FEBS Lett 565: 122-6 [PMID:15135064]
101. Narjes F, Llinas A, von Berg S, Jirholt J, Lever S, Pehrson R, Collins M, Malmberg M, Svanberg P and Xue Y et al.. (2021) AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2 Journal of Medicinal Chemistry [PMID:34464130]
102. Nguyen A, Rauch TA, Pfeifer GP and Hu VW. (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 24: 3036-51 [PMID:20375269]
103. Noguchi M, Nomura A, Murase K, Doi S, Yamaguchi K, Hirata K, Shiozaki M, Hirashima S, Kotoku M and Yamaguchi T et al.. (2017) Ternary complex of human RORγ ligand-binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment. Genes Cells 22: 535-551 [PMID:28493531]
104. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS and Jetten AM et al.. (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-3 [PMID:17581589]
105. Ortiz MA, Piedrafita FJ, Pfahl M and Maki R. (1995) TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol Endocrinol 9: 1679-91 [PMID:8614404]
106. Ou Z, Shi X, Gilroy RK, Kirisci L, Romkes M, Lynch C, Wang H, Xu M, Jiang M and Ren S et al.. (2013) Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases. Mol Endocrinol 27: 106-15 [PMID:23211525]
107. Paravicini G, Steinmayr M, André E and Becker-André M. (1996) The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily. Biochem Biophys Res Commun 227: 82-7 [PMID:8858107]
108. Pathak P, Li T and Chiang JY. (2013) Retinoic acid-related orphan receptor α regulates diurnal rhythm and fasting induction of sterol 12α-hydroxylase in bile acid synthesis. J Biol Chem 288: 37154-65 [PMID:24226095]
109. Raichur S, Fitzsimmons RL, Myers SA, Pearen MA, Lau P, Eriksson N, Wang SM and Muscat GE. (2010) Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle. Nucleic Acids Res 38: 4296-312 [PMID:20338882]
110. Raichur S, Lau P, Staels B and Muscat GE. (2007) Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production. J Mol Endocrinol 39: 29-44 [PMID:17601883]
111. Ramasamy A, Kuokkanen M, Vedantam S, Gajdos ZK, Couto Alves A, Lyon HN, Ferreira MA, Strachan DP, Zhao JH and Abramson MJ et al.. (2012) Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. PLoS ONE 7: e44008 [PMID:23028483]
112. Raspè E, Mautino G, Duval C, Fontaine C, Duez H, Barbier O, Monte D, Fruchart J, Fruchart JC and Staels B. (2002) Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha. J Biol Chem 277: 49275-81 [PMID:12377782]
113. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST and McKenzie AN et al.. (2013) A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210: 2939-50 [PMID:24323357]
114. Santarlasci V, Maggi L, Capone M, Querci V, Beltrame L, Cavalieri D, D'Aiuto E, Cimaz R, Nebbioso A and Liotta F et al.. (2012) Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 36: 201-14 [PMID:22326581]
115. Santori FR, Huang P, van de Pavert SA, Douglass Jr EF, Leaver DJ, Haubrich BA, Keber R, Lorbek G, Konijn T and Rosales BN et al.. (2015) Identification of natural RORγ ligands that regulate the development of lymphoid cells. Cell Metab 21: 286-97 [PMID:25651181]
116. Sarachana T and Hu VW. (2013) Differential recruitment of coregulators to the RORA promoter adds another layer of complexity to gene (dys) regulation by sex hormones in autism. Mol Autism 4: 39 [PMID:24119295]
117. Sarachana T and Hu VW. (2013) Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder. Mol Autism 4: 14 [PMID:23697635]
118. Sarachana T, Xu M, Wu RC and Hu VW. (2011) Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLoS ONE 6: e17116 [PMID:21359227]
119. Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA and Hogenesch JB. (2004) A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43: 527-37 [PMID:15312651]
120. Schaeren-Wiemers N, André E, Kapfhammer JP and Becker-André M. (1997) The expression pattern of the orphan nuclear receptor RORbeta in the developing and adult rat nervous system suggests a role in the processing of sensory information and in circadian rhythm. Eur J Neurosci 9: 2687-701 [PMID:9517474]
121. Schnute ME, Trujillo JI, Lee KL, Unwalla R, Vajdos FF, Kauppi B, Nuhant P, Flick AC, Crouse KK and Zhao Y et al.. (2023) Macrocyclic Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonists ACS Medicinal Chemistry Letters
122. Schnute ME, Wennerstål M, Alley J, Bengtsson M, Blinn JR, Bolten CW, Braden T, Bonn T, Carlsson B and Caspers N et al.. (2018) Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist. J Med Chem 61: 10415-10439 [PMID:30130103]
123. Serafini N, Klein Wolterink RG, Satoh-Takayama N, Xu W, Vosshenrich CA, Hendriks RW and Di Santo JP. (2014) Gata3 drives development of RORγt+ group 3 innate lymphoid cells. J Exp Med 211: 199-208 [PMID:24419270]
124. Skepner J, Ramesh R, Trocha M, Schmidt D, Baloglu E, Lobera M, Carlson T, Hill J, Orband-Miller LA and Barnes A et al.. (2014) Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J Immunol 192: 2564-75 [PMID:24516202]
125. Slominski AT, Kim TK, Takeda Y, Janjetovic Z, Brozyna AA, Skobowiat C, Wang J, Postlethwaite A, Li W and Tuckey RC et al.. (2014) RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J 28: 2775-89 [PMID:24668754]
126. Smith SH, Peredo CE, Takeda Y, Bui T, Neil J, Rickard D, Millerman E, Therrien JP, Nicodeme E and Brusq JM et al.. (2016) Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin. PLoS ONE 11: e0147979 [PMID:26870941]
127. Solt LA, Banerjee S, Campbell S, Kamenecka TM and Burris TP. (2015) ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Endocrinology 156: 869-81 [PMID:25560829]
128. Solt LA and Burris TP. (2012) Action of RORs and their ligands in (patho)physiology. Trends Endocrinol Metab 23: 619-27 [PMID:22789990]
129. Solt LA, Kojetin DJ and Burris TP. (2011) The REV-ERBs and RORs: molecular links between circadian rhythms and lipid homeostasis. Future Med Chem 3: 623-38 [PMID:21526899]
130. Solt LA, Kumar N, He Y, Kamenecka TM, Griffin PR and Burris TP. (2012) Identification of a selective RORγ ligand that suppresses T(H)17 cells and stimulates T regulatory cells. ACS Chem Biol 7: 1515-9 [PMID:22769242]
131. Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J, Istrate MA, Kamenecka TM, Roush WR and Vidović D et al.. (2011) Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472: 491-4 [PMID:21499262]
132. Song Y, Xue X, Wu X, Wang R, Xing Y, Yan W, Zhou Y, Qian CN, Zhang Y and Xu Y. (2016) Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation. Eur J Med Chem 116: 13-26 [PMID:27043267]
133. Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Schüle R, Moras D and Renaud JP. (2001) X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J 20: 5822-31 [PMID:11689423]
134. Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D and Schüle R. (2003) All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 10: 820-5 [PMID:12958591]
135. Steinmayr M, André E, Conquet F, Rondi-Reig L, Delhaye-Bouchaud N, Auclair N, Daniel H, Crépel F, Mariani J, Sotelo C and Becker-André M. (1998) staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci USA 95: 3960-5 [PMID:9520475]
136. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD and Altschul SF et al.. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-903 [PMID:12477932]
137. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE and Littman DR. (2000) Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288: 2369-73 [PMID:10875923]
138. Takeda Y and Jetten AM. (2013) Prospero-related homeobox 1 (Prox1) functions as a novel modulator of retinoic acid-related orphan receptors α- and γ-mediated transactivation. Nucleic Acids Res 41: 6992-7008 [PMID:23723244]
139. Takeda Y, Jothi R, Birault V and Jetten AM. (2012) RORγ directly regulates the circadian expression of clock genes and downstream targets in vivo. Nucleic Acids Res 40: 8519-35 [PMID:22753030]
140. Takeda Y, Kang HS, Angers M and Jetten AM. (2011) Retinoic acid-related orphan receptor γ directly regulates neuronal PAS domain protein 2 transcription in vivo. Nucleic Acids Res 39: 4769-82 [PMID:21317191]
141. Takeda Y, Kang HS, Freudenberg J, DeGraff LM, Jothi R and Jetten AM. (2014) Retinoic acid-related orphan receptor γ (RORγ): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. PLoS Genet 10: e1004331 [PMID:24831725]
142. Takeda Y, Kang HS, Lih FB, Jiang H, Blaner WS and Jetten AM. (2014) Retinoid acid-related orphan receptor γ, RORγ, participates in diurnal transcriptional regulation of lipid metabolic genes. Nucleic Acids Res 42: 10448-59 [PMID:25143535]
143. Tilley SL, Jaradat M, Stapleton C, Dixon D, Hua X, Erikson CJ, McCaskill JG, Chason KD, Liao G and Jania L et al.. (2007) Retinoid-related orphan receptor gamma controls immunoglobulin production and Th1/Th2 cytokine balance in the adaptive immune response to allergen. J Immunol 178: 3208-18 [PMID:17312169]
144. Tinahones FJ, Moreno-Santos I, Vendrell J, Chacon MR, Garrido-Sanchez L, García-Fuentes E and Macias-González M. (2012) The retinoic acid receptor-related orphan nuclear receptor γ1 (RORγ1): a novel player determinant of insulin sensitivity in morbid obesity. Obesity (Silver Spring) 20: 488-97 [PMID:21904299]
145. Tini M, Fraser RA and Giguère V. (1995) Functional interactions between retinoic acid receptor-related orphan nuclear receptor (ROR alpha) and the retinoic acid receptors in the regulation of the gamma F-crystallin promoter. J Biol Chem 270: 20156-61 [PMID:7650034]
146. Tuong ZK, Lau P, Yeo JC, Pearen MA, Wall AA, Stanley AC, Stow JL and Muscat GE. (2013) Disruption of Rorα1 and cholesterol 25-hydroxylase expression attenuates phagocytosis in male Rorαsg/sg mice. Endocrinology 154: 140-9 [PMID:23239817]
147. van de Pavert SA, Ferreira M, Domingues RG, Ribeiro H, Molenaar R, Moreira-Santos L, Almeida FF, Ibiza S, Barbosa I and Goverse G et al.. (2014) Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508: 123-7 [PMID:24670648]
148. van Niel MB, Fauber BP, Cartwright M, Gaines S, Killen JC, René O, Ward SI, de Leon Boenig G, Deng Y and Eidenschenk C et al.. (2014) A reversed sulfonamide series of selective RORc inverse agonists. Bioorg Med Chem Lett 24: 5769-76 [PMID:25453817]
149. Wada T, Kang HS, Angers M, Gong H, Bhatia S, Khadem S, Ren S, Ellis E, Strom SC and Jetten AM et al.. (2008) Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol 73: 891-9 [PMID:18055760]
150. Walker JA, Barlow JL and McKenzie AN. (2013) Innate lymphoid cells--how did we miss them? Nat Rev Immunol 13: 75-87 [PMID:23292121]
151. Wang Y, Kumar N, Crumbley C, Griffin PR and Burris TP. (2010) A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim Biophys Acta 1801: 917-23 [PMID:20211758]
152. Wang Y, Kumar N, Solt LA, Richardson TI, Helvering LM, Crumbley C, Garcia-Ordonez RD, Stayrook KR, Zhang X and Novick S et al.. (2010) Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands. J Biol Chem 285: 5013-25 [PMID:19965867]
153. Wang Y, Solt LA and Burris TP. (2010) Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha. J Biol Chem 285: 15668-73 [PMID:20332535]
154. Wiesenberg I, Missbach M, Kahlen JP, Schräder M and Carlberg C. (1995) Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 23: 327-33 [PMID:7885826]
155. Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V and Koch U et al.. (2012) Transcription factor RORα is critical for nuocyte development. Nat Immunol 13: 229-36 [PMID:22267218]
156. Xiao S, Yosef N, Yang J, Wang Y, Zhou L, Zhu C, Wu C, Baloglu E, Schmidt D and Ramesh R et al.. (2014) Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity 40: 477-89 [PMID:24745332]
157. Xu T, Wang X, Zhong B, Nurieva RI, Ding S and Dong C. (2011) Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein. J Biol Chem 286: 22707-10 [PMID:21566134]
158. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD and Schluns KS et al.. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28: 29-39 [PMID:18164222]
159. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, Awasthi A, Wu C, Karwacz K, Xiao S and Jorgolli M et al.. (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496: 461-8 [PMID:23467089]
160. Yu X, Rollins D, Ruhn KA, Stubblefield JJ, Green CB, Kashiwada M, Rothman PB, Takahashi JS and Hooper LV. (2013) TH17 cell differentiation is regulated by the circadian clock. Science 342: 727-30 [PMID:24202171]
161. Zhang F, Meng G and Strober W. (2008) Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol 9: 1297-306 [PMID:18849990]
162. Zhang H, Lapointe BT, Anthony N, Azevedo R, Cals J, Correll CC, Daniels M, Deshmukh S, van Eenenaam H and Ferguson H et al.. (2020) Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases. ACS Med Chem Lett 11: 114-119 [PMID:32071676]
163. Zhang Y, Wu X, Xue X, Li C, Wang J, Wang R, Zhang C, Wang C, Shi Y and Zou L et al.. (2019) Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. J Med Chem 62: 4716-4730 [PMID:30964293]
164. Zhao X, Graves C, Ames SJ, Fisher DE and Spanjaard RA. (2009) Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. Cancer Res 69: 5218-25 [PMID:19470764]